Results 91 to 100 of about 223,878 (259)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To identify inflammatory analytes in cerebrospinal fluid (CSF) and plasma associated with cognitive decline in cognitively normal (CN) older adults at risk for Alzheimer's disease (AD). Methods In a longitudinal study of 118 CN older adults (65–80 years, 54% APOE ε4, 26% preclinical AD), 1331 CSF and 1501 plasma analytes were ...
Jagan A. Pillai +13 more
wiley +1 more source
microRNA‐7‐5p and α‐Synuclein SAA Predict Parkinson's Disease Phenoconversion
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Corroborate blood neuron‐derived extracellular vesicle (NDEV) alpha‐synuclein (αSyn), the CSF αSyn seed amplification assay (αSyn‐SAA), and blood microRNA‐7‐5p (miR‐7‐5p) as markers for Parkinson's disease (PD) phenoconversion and determine if combining these markers would help select subjects who would be more likely to phenoconvert.
Shayan Zadegan +4 more
wiley +1 more source
Exercise benefits on motor and non motor symptoms on Parkinson disease
, 2022 openLa malattia di Parkinson è la seconda malattia neurodegenerativa più comune al mondo. Secondo le stime dell'OMS, entro il 2030 i pazienti Parkinson saranno il doppio di quelli attuali, pertanto è importante trovare soluzioni efficaci alternative ...
MENTI, MARIA CRISTINA
core
Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley +1 more source
Professor C. Northcote Parkinson speaks at Australian Institute of Management seminar, 1981
, 1981 Professor C. Northcote Parkinson, world-renowned author, lecturer, journalist and historian. The professor spoke at a seminar at the Australian Institute of Management.
Swinburne Institute of Technology
core +1 more source
Current update on the protective effect of epicatechin in neurodegenerative diseases
EXCLI Journal : Experimental and Clinical Sciences, 2022 Riya Thapa +9 more
doaj +1 more source
Stage‐Specific Patterns of Imaging and Non‐Motor Biomarkers in Spinocerebellar Ataxia Type 3
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Advancements in disease‐modifying therapies for spinocerebellar ataxia Type 3 (SCA3) underscore the need for robust biomarkers to monitor disease progression and evaluate treatment efficacy. Although motor phenotypes have been well characterized, less is known about non‐motor and imaging‐based features across different disease stages.
Chun Li +17 more
wiley +1 more source
L - R: Clark Parkinson, Tony Parkinson. Sun Valley, Idaho
, 1990 Photo of Clark and Tony Parkinson skiing at Sun Valley ...
core
Arthritis Care &Research, EarlyView.Objective The objective of this scoping review was to synthesize evidence on the proportion of individuals living with Sjögren's disease who experience central nervous system (CNS) manifestations. Methods We searched MEDLINE (via PubMed) and Embase from 1980 through January 29, 2026, and the ECRI Guidelines Trust from 2020 through January 29, 2026 ...
Arun Varadhachary +21 more
wiley +1 more source
Assessment of Geriatric Foot using the Baropodometric P-walk Platform
Bulletin of the Transilvania University of Braşov: Series IX Sciences of Human Kinetics, 2023 The purpose of this study was to identify foot typology in senior individuals using barapodometry as an evaluation tool. 20 individuals, with a mean age of 74,35 years (15 female and 5 male), were enrolled in the study.
P.L. Haisan, D. Monea, V.T. Grosu
doaj